PHILADELPHIA, PA (January 22, 2021) – Advancements in diabetes technology have improved quality of life and glycemic control in children with type 1 diabetes. However, data show that a subset of children is being left behind. Those from low-income families and non-Hispanic Black (NHB) children are not experiencing […]
Research team determines that the “Immune only” focus of current research must be updated to better understand autoimmune diseases such as type 1 diabetes and multiple sclerosis Indianapolis, Ind. – A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center’s Scientific Director Decio L. Eizirik, […]
Dr. Camilo Ricordi, director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, and his team of international collaborators are reporting the results of a groundbreaking randomized controlled trial showing umbilical cord-derived mesenchymal stem cell (UC-MSC) infusions safely […]
Islet allotransplantation in the United States (US) is facing an imminent demise. Despite nearly three decades of progress in the field, an archaic regulatory framework has stymied US clinical practice. Current regulations do not reflect the state-of-the-art in clinical or technical practices. In the US, islets are considered […]
Impatto sostenuto del monitoraggio continuo del glucosio in tempo reale negli adulti con diabete di tipo 1 sulla terapia con microinfusore: risultati dopo lo studio RESCUE di 24 mesi. Negli ultimi anni, un numero crescente di persone con diabete di tipo 1 ha ottenuto l’accesso al monitoraggio continuo […]
Commenti recenti